Gland Pharma jumps 5% after USFDA nod for Vitamin-K deficiency drug

Quick Summary:

Shares of Gland Pharma surged up to 4.

Gland Pharma jumps 5% after USFDA nod for Vitamin-K deficiency drugShares of Gland Pharma surged up to 4.

The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Vitamin K1 Injectable Emulsion, of Hospira, Inc.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaUnited States

Topics: Gland Pharma share price today Buzzing stocks Gland Pharma news Gland Pharma Gland Pharma share price Gland Pharma shares Stock market Sensex Gland Pharma share price

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-12 @ 09:48:41 (4 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 476 words

Reading Time: 3 minutes read

Sentences: 23 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 24367935

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 272 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions